Glimelius B - Search Results

1

TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: a potential novel approach to the treatment of metastatic colorectal cancer.

Tarpgaard LS, Ørum-Madsen MS, Christensen IJ, Nordgaard C, Noer J, Guren TK, Glimelius B, Sorbye H, Ikdahl T, Kure EH, Tveit KM, Nielsen HJ, Pfeiffer P, Brünner N, Moreira JM. Tarpgaard LS, et al. Among authors: glimelius b. Oncotarget. 2016 Sep 13;7(37):59441-59457. doi: 10.18632/oncotarget.11118. Oncotarget. 2016. PMID: 27509063 Free PMC article. Clinical Trial.

2

Multicenter phase II study of Nordic fluorouracil and folinic acid bolus schedule combined with oxaliplatin as first-line treatment of metastatic colorectal cancer.

Sørbye H, Glimelius B, Berglund A, Fokstuen T, Tveit KM, Braendengen M, Øgreid D, Dahl O. Sørbye H, et al. Among authors: glimelius b. J Clin Oncol. 2004 Jan 1;22(1):31-8. doi: 10.1200/JCO.2004.05.188. J Clin Oncol. 2004. PMID: 14701765 Clinical Trial.

3

A phase II study of UFT and Leucovorin in combination with mitomycin C in patients with metastatic colorectal cancer.

Gyldenkerne N, Glimelius B, Frödin JE, Kjaer M, Pfeiffer P, Hansen F, Keldsen N, Sandberg E, Jakobsen A. Gyldenkerne N, et al. Among authors: glimelius b. Acta Oncol. 2004;43(3):276-9. doi: 10.1080/02841860410028655. Acta Oncol. 2004. PMID: 15244251 Clinical Trial.

4

TIMP-1 is significantly associated with objective response and survival in metastatic colorectal cancer patients receiving combination of irinotecan, 5-fluorouracil, and folinic acid.

Sørensen NM, Byström P, Christensen IJ, Berglund A, Nielsen HJ, Brünner N, Glimelius B. Sørensen NM, et al. Among authors: glimelius b. Clin Cancer Res. 2007 Jul 15;13(14):4117-22. doi: 10.1158/1078-0432.CCR-07-0186. Clin Cancer Res. 2007. PMID: 17634538 Clinical Trial.

5

Secondary treatment and predictive factors for second-line chemotherapy after first-line oxaliplatin-based therapy in metastatic colorectal cancer.

Sørbye H, Berglund A, Tveit KM, Ogreid D, Wanderås EH, Wentzel-Larsen T, Dahl O, Glimelius B. Sørbye H, et al. Among authors: glimelius b. Acta Oncol. 2007;46(7):982-8. doi: 10.1080/02841860701261568. Acta Oncol. 2007. PMID: 17917829 Clinical Trial.

6

Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer.

Braendengen M, Tveit KM, Berglund A, Birkemeyer E, Frykholm G, Påhlman L, Wiig JN, Byström P, Bujko K, Glimelius B. Braendengen M, et al. Among authors: glimelius b. J Clin Oncol. 2008 Aug 1;26(22):3687-94. doi: 10.1200/JCO.2007.15.3858. J Clin Oncol. 2008. PMID: 18669453 Clinical Trial.

7

Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients.

Sorbye H, Pfeiffer P, Cavalli-Björkman N, Qvortrup C, Holsen MH, Wentzel-Larsen T, Glimelius B. Sorbye H, et al. Among authors: glimelius b. Cancer. 2009 Oct 15;115(20):4679-87. doi: 10.1002/cncr.24527. Cancer. 2009. PMID: 19562777 Free article.

8

Preoperative plasma TIMP-1 is an independent prognostic indicator in patients with primary colorectal cancer: a prospective validation study.

Birgisson H, Nielsen HJ, Christensen IJ, Glimelius B, Brünner N. Birgisson H, et al. Among authors: glimelius b. Eur J Cancer. 2010 Dec;46(18):3323-31. doi: 10.1016/j.ejca.2010.06.009. Epub 2010 Jul 7. Eur J Cancer. 2010. PMID: 20619633

9

Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized Phase III study.

Brændengen M, Tveit KM, Bruheim K, Cvancarova M, Berglund Å, Glimelius B. Brændengen M, et al. Among authors: glimelius b. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1017-24. doi: 10.1016/j.ijrobp.2010.07.007. Epub 2010 Oct 6. Int J Radiat Oncol Biol Phys. 2011. PMID: 20932687 Clinical Trial.

10

KRAS analysis in colorectal carcinoma: analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice.

Sundström M, Edlund K, Lindell M, Glimelius B, Birgisson H, Micke P, Botling J. Sundström M, et al. Among authors: glimelius b. BMC Cancer. 2010 Dec 1;10:660. doi: 10.1186/1471-2407-10-660. BMC Cancer. 2010. PMID: 21122130 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

841 results

Search Page